CheckMyRecalls

Amneal Pharmaceuticals of New York, LLC recalls Exenatide Injection

Published
30 Sept 2026
Units affected
5,694 pens
Agency
FDA
Country
United States

The hazard

Defective Delivery System: Possibility of no medication in the prefilled pen.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1

Brand / company
Amneal Pharmaceuticals of New York, LLC
Codes / lots
Lot #: AP250095A, Exp 2/28/2027
Distribution
USA Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 30 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.